Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists.
Australas J Dermatol
; 53(4): e87-90, 2012 Nov.
Article
em En
| MEDLINE
| ID: mdl-23157794
ABSTRACT
The use of tumour necrosis factor alpha (TNF-α) antagonists is increasing in the field of dermatology. These agents have been used for multiple inflammatory and immune skin conditions, but most notably, psoriasis. Adverse effects of anti-TNF-α agents have been reported, including the paradoxical development of sarcoidosis. We present an unusual case of limited cutaneous sarcoidosis developing while the patient was on etanercept therapy, and a review of the current literature.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Sarcoidose
/
Dermatopatias
/
Imunoglobulina G
/
Fator de Necrose Tumoral alfa
/
Toxidermias
/
Imunossupressores
Limite:
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Australas J Dermatol
Ano de publicação:
2012
Tipo de documento:
Article